CLAIRITY, INC.

Profile

Company Names

CLAIRITY, INC.

Addresses

C/O CLAIRITY, INC., 201 WEST 5TH STREET, STE 1500, AUSTIN, TX 78701

Phone Numbers

774-284-5912

 

Entity Type:

CORPORATION

Industry:

OTHER HEALTH CARE

Year Incorporated:

2019

State Incorporated:

DELAWARE

Total Amount Raised:

$10,466,681.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2022-09-30 
$6,666,685.00 
$29,999,979.00 
$23,333,294.00 
Equity 
1
2021-01-26 
$3,799,996.00 
$8,950,619.00 
$5,150,623.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GABRIELLA 
 
ANTICI 
DIRECTOR
DRCONSULTA LTD.   |  CLAIRITY, INC.
JOE 
 
CUNNINGHAM 
DIRECTOR
D5 PHARMA, INC.   |  MILLIPEDE, INC.   |  BETA CAT PHARMACEUTICALS, INC.   |  REMEDY APPLICATIONS INC.   |  BIOSTABLE SCIENCE + ENGINEERING INC   |  CLAIRITY, INC.
CAROLINE 
 
IVERS REEUWIJK 
EXECUTIVE OFFICER, DIRECTOR
CLAIRITY, INC.
KEVIN 
 
LALANDE 
EXECUTIVE OFFICER, DIRECTOR
HOSPITALISTS NOW, INC.   |  D5 PHARMA, INC.   |  TERAPIO CORP   |  SPINAL RESTORATION INC   |  ZENO CORP   |  MOLECULAR TEMPLATES, INC.   |  LDR HOLDING CORP   |  CHANRX CORP.   |  LYRIC PHARMACEUTICALS INC.   |  LAGUNA PHARMACEUTICALS, INC.   |  SANTE CAPITAL FUND, LP   |  CLAIRITY, INC.   |  SENSORIUM THERAPEUTICS, INC.   |  MOLECULAR TEMPLATES, INC.
PHILLIPPE 
 
RAFFY 
EXECUTIVE OFFICER
CLAIRITY, INC.
BRANDON 
 
WEAVER 
EXECUTIVE OFFICER
CLAIRITY, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2022-10-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2022-09-30 
2021-02-10
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-01-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#